NASDAQ · Biotechnology

MorphoSys AG ADR (MOR)

$18.96 0.00%

Add alert

57 In band Daily RSI (14)

Moving averages

SMA 200$14.73+28.72%

Company profile

MorphoSys AG, discovers, develops and markets therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. The company is headquartered in Planegg, Germany.

SectorHealthcare

IndustryBiotechnology

Market cap$2.86B

P/E ratioNone

EPS$-1.50

Beta0.662

Dividend yield0.00%

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 44 VRTX Vertex Pharmaceuticals Inc RSI 44 CRSP CRISPR Therapeutics AG RSI 39 IOVA Iovance Biotherapeutics Inc RSI 63 MRNA Moderna Inc RSI 61 VKTX Viking Therapeutics Inc RSI 42 SRPT Sarepta Therapeutics Inc RSI 53 EDIT Editas Medicine Inc RSI 41 NVAX Novavax Inc RSI 54 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 42

Free forever

RSI alerts for MOR

Get an email the moment MorphoSys AG ADR crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 16 August 2026 at 3:32 AM EDT